Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand

Presented at TIDES Europe, November 13, 2024

Speaker: Jan Pawlas, Scientist Global Development

Abstract: The peptide market is strongly impacted by the evolution of the development pipeline, in particular for the treatments that require massive volumes of drugs, driven by the booming demand for metabolic diseases. The scale-up of the existing technology platform to produce synthetic peptides is a major challenge to reach the expected volumes. The current manufacturing technology platform needs to evolve in order to deliver both sustainable and cost-effective solutions. PolyPeptide is a leading CDMO organization, with the capabilities to efficiently adapt to the emerging requirements and to deliver the most effective and sustainable solutions to develop and manufacture your peptides.